Results 51 to 60 of about 232,449 (132)

IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia

open access: yesFrontiers in Oncology
BackgroundRecurrent genetic alterations contributing to leukemogenesis have been identified in pediatric B-cell Acute Lymphoblastic Leukemia (B-ALL), and some are useful for refining classification, prognosis, and treatment selection.
Joaquin Garcia-Solorio   +40 more
doaj   +1 more source

Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival [PDF]

open access: yes, 2012
Recent evidence suggests CML stem cells are insensitive to kinase inhibitors and responsible for minimal residual disease in treated patients. We investigated whether CML stem cells, in a transgenic mouse model of CML-like disease or derived from ...
Allan, Elaine K.   +18 more
core   +1 more source

Posterior reversible encephalopathy syndrome after CD19 chimeric antigen receptor therapy for B-acute lymphoblastic leukemia: case report

open access: yesFrontiers in Oncology
Posterior reversible encephalopathy syndrome (PRES) is a neurologic condition characterized by distinctive radiologic findings and altered mental status, often associated with chemotherapy or systemic endothelial dysfunction.
Rohan Dipesh Agarwal   +2 more
doaj   +1 more source

6-Mercaptopurine-induced fever in a case of B-acute lymphoblastic leukemia: A case report

open access: yesCancer Research, Statistics, and Treatment, 2022
Saroj Bala   +4 more
doaj   +1 more source

Expression of CD123 in B-Acute Lymphoblastic Leukemia as a Predictor of BCR/ABL rearrangement and Disease Relapse

open access: yesBasic & Clinical Cancer Research
Introduction: CD123 is the alpha chain of the interleukin 3 receptor (IL-3R) and normally expressed on hematopoietic progenitor cells, monocytes, B lymphocytes and endothelial cells.
Birva Nimit Raiya
doaj   +1 more source

Acute and early-onset cardiotoxicity in children and adolescents with cancer: a systematic review. [PDF]

open access: yesBMC Cancer, 2023
Kouwenberg TW   +9 more
europepmc   +1 more source

Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment [PDF]

open access: yes, 2009
Background: t(9;22) is a balanced translocation, and the chromosome 22 breakpoints (Philadelphia chromosome – Ph+) determine formation of different fusion genes that are associated with either Ph+ acute lymphatic leukemia (Ph+ ALL) or chronic myeloid ...
Xiaomin Zheng   +10 more
core   +2 more sources

A Case Report of Central Nervous System Graft-Versus-Host Disease and Literature Review. [PDF]

open access: yesFront Neurol, 2021
Li M   +6 more
europepmc   +1 more source

Results of chemotherapy by UKCCSG protocol in children with acute lymphoblastic leukemia: Clinical characteristics and outcome [PDF]

open access: yes
Background: Acute lymphoblastic leukemia (ALL) represents a clonal expansion and arrest of normal lymphoid hematopoiesis. ALL remains the most common malignancy in children.
پدرام, محمد   +2 more
core  

Rare Coexistence of Atypical Chronic Lymphocytic Leukemia and B-Acute Lymphoblastic Leukemia in a Patient Followed Up for Monoclonal B-Cell Lymphocytosis

open access: yesHemato
Monoclonal B Lymphocytosis (MBL) is considered the pre-malignant state of chronic lymphocytic leukemia (CLL) and atypical chronic lymphocytic leukemia (aCLL).
Fabio Bertani   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy